The trial was designed to evaluate the therapy’s efficacy and safety in treating AML, as well as myelodysplastic syndromes.

Tevogen Bio remains steadfast in its mission to pioneer accessible and affordable precision medicine while advocating for ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

"Health Canada approves Novartis’ Fabhalta for PNH with haemolytic anaemia" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The info ...

Positive IHL-42X PK findings for the treatment of Obstructive Sleep Apnea (OSA) support future 505(b)(2) New Drug Application (NDA) submissionNew OSA Clinical Advisory Board Announced; Appoints Dr. Al ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...

Brisbane won their opening match of the trials 46-20 against the Cowboys before a second-string side beat Manly 20-14 the following week to lock in a perfect record. Joshua Mayne is a content ...

The Department of Agriculture (DA) imposed a temporary ban on products from animals susceptible to foot and mouth disease (FMD) in Germany.